On a Tuesday evening in Kazakhstan, a column of fire carried three human beings into orbit — among them Anil Menon, a Minneapolis-born physician and engineer whose parents came from India and Ukraine, now embarking on his first journey beyond Earth. The Soyuz MS-29 mission to the International Space Station is more than a personal milestone; it is part of the slow, deliberate work of learning whether our bodies and our technologies can sustain human life far from home. Over eight months, Menon and his crewmates will probe the physiology of weightlessness and test medical tools designed for voy
Indian-Origin Astronaut Anil Menon Launches on Maiden ISS Mission Aboard Soyuz
Converting a resource the crew already needs into a medical necessity
Mark
Why does it matter that Menon is studying blood circulation and vein structure in microgravity? What changes?
Mimi
In zero gravity, your cardiovascular system doesn't have to fight gravity anymore. Blood pools differently. Veins and arteries adapt. If we don't understand those changes, we can't predict what happens to an astronaut's heart and blood vessels on a six-month mission to Mars.
Luke
But we've had astronauts in space for decades. Haven't we already learned this?
Mimi
We have learned some of it. But every body is different, and the data is still incomplete. Menon's research is adding to a library of observations.
Mark
What about the IV fluid system—how does that actually work?
Mimi
The station has drinking water. The system purifies it further and adds the electrolytes and nutrients that IV fluids contain. It's elegant because it solves a real problem: you can't resupply a spacecraft halfway to Mars.
Luke
Has it been tested on Earth?
Mimi
Yes, but not in actual microgravity, with actual astronauts using it under real mission conditions. That's what Menon will do.
Mark
And the AI-assisted ultrasound—is that ready to use, or is this still experimental?
Mimi
It's being developed and tested. Menon will help demonstrate whether it works in practice, whether an astronaut without medical training can follow the AI's guidance and get useful diagnostic information.
Luke
So these aren't finished technologies. They're being validated in space.
Mimi
Exactly. The ISS is a laboratory for testing systems that will eventually be used on deep-space missions where you can't call Earth for help.
Le Pouls
- A Soyuz capsule lifted off from Baikonur Cosmodrome at 8:17 pm local time, carrying Menon on his first spaceflight alongside two veteran Russian cosmonauts making their second trips to orbit.
- The mission carries real urgency: deep-space travel will demand that crews manage medical emergencies entirely on their own, without resupply or specialist support — a problem that remains unsolved.
- Menon's research targets the body's response to microgravity — tracking blood circulation, vein structure, and blood composition — to determine what it actually takes to keep a human being healthy in space for months at a time.
- A system that converts drinking water into intravenous fluids is being tested aboard the station, a technology that could become a lifeline on missions where carrying medical supplies from Earth is simply not possible.
- AI-guided ultrasound and augmented reality overlays are being trialed to allow non-specialist crew members to perform medical diagnostics — redistributing the role of the physician across the crew itself.
- The crew is expected to return in 2027, carrying data that will shape how humanity plans to live and work beyond Earth for generations to come.
On a Tuesday evening in Kazakhstan, a column of fire carried three human beings into orbit — among them Anil Menon, a Minneapolis-born physician and engineer whose parents came from India and Ukraine, now embarking on his first journey beyond Earth. The Soyuz MS-29 mission to the International Space Station is more than a personal milestone; it is part of the slow, deliberate work of learning whether our bodies and our technologies can sustain human life far from home. Over eight months, Menon and his crewmates will probe the physiology of weightlessness and test medical tools designed for voyages to the Moon and Mars — places where no resupply ship will come and no doctor will be waiting.
Anil Menon lifted off from the Baikonur Cosmodrome in Kazakhstan on Tuesday evening aboard Soyuz MS-29, joining Russian cosmonauts Pyotr Dubrov and Anna Kikina for an eight-month stay on the International Space Station. For Menon — a NASA astronaut born in Minneapolis to parents who immigrated from India and Ukraine — it was a first journey to space. For his crewmates, it was a return to familiar orbit. The spacecraft docked with the ISS just over three hours after launch.
Menon's preparation for this mission is unusually broad: he holds degrees in neurobiology, mechanical engineering, and medicine. Much of his time aboard the station will be spent studying how the human body responds to microgravity — examining blood circulation, vein structure, and shifts in blood composition. These findings are foundational to understanding whether long-duration spaceflight is medically viable, and what interventions might be needed to protect future crews.
Two technologies at the center of his mission point toward the practical demands of deep-space travel. The first is a system that produces intravenous fluids from drinking water — a potential solution to the impossibility of resupplying medical stores on a journey to the Moon or Mars. The second involves AI-assisted ultrasound procedures guided by augmented reality, designed to allow astronauts without medical training to diagnose and treat conditions that would otherwise require a physician. Together, they represent a rethinking of what medical care in space can look like.
Menon's launch is in one sense routine — Soyuz flights to the ISS follow a practiced rhythm. But it also marks something quieter and more significant: the continued normalization of space as a place where people of all origins contribute to knowledge that belongs to everyone. The work this crew conducts before returning to Earth in 2027 will inform how humanity approaches the longer journeys still ahead.
Anil Menon strapped into a Soyuz capsule at the Baikonur Cosmodrome in Kazakhstan on Tuesday evening and rode a column of flame into orbit. At 8:17 pm local time, the spacecraft lifted off carrying Menon, a NASA astronaut of Indian descent, alongside Russian cosmonauts Pyotr Dubrov and Anna Kikina. For Menon, born in Minneapolis to parents who had immigrated from India and Ukraine, this was the culmination of years of training—his first journey to space. For Dubrov and Kikina, it was familiar ground; both were returning to orbit for a second time.
The Soyuz MS-29 docked with the International Space Station just over three hours after launch, beginning an eight-month expedition that will keep the three crew members aboard the orbital laboratory until 2027. What unfolds in that time will be a carefully orchestrated sequence of scientific investigations and medical demonstrations, each one designed to answer questions that matter for the future of human spaceflight.
Menon's background prepared him for this work in ways that few careers could. He holds degrees in neurobiology, mechanical engineering, and medicine—a combination that reflects both the breadth of knowledge space research demands and the specificity of his assigned tasks. Much of his time on the station will be devoted to understanding how the human body adapts to microgravity. His team will study blood circulation patterns, examine changes in vein structure, and analyze shifts in blood composition. These are not abstract questions. They are the foundation for knowing whether humans can safely spend months or years in space, and what interventions might be necessary to keep them healthy.
One of the technologies Menon will help evaluate addresses a practical problem that becomes urgent on longer missions. The station currently carries supplies of intravenous fluids for medical emergencies and routine care. But on a journey to the Moon or Mars, resupply is impossible. NASA and its partners have developed a system that can produce IV fluids from drinking water—converting a resource the crew already needs into a medical necessity. Testing this system in the actual environment where it would be used, with actual astronauts monitoring its performance, is the only way to know if it will work when lives depend on it.
Beyond that, Menon will participate in advanced medical demonstrations that blend emerging technologies in ways that sound like science fiction but are being built today. He will assist in ultrasound procedures guided by augmented reality and artificial intelligence—systems that could allow astronauts on deep-space missions to diagnose and treat medical problems without the presence of a trained physician. An AI system trained on thousands of ultrasound images can guide a non-specialist through the procedure, highlighting where to place the probe and what to look for. Augmented reality can overlay anatomical landmarks and diagnostic information directly into the astronaut's field of view. Together, these tools represent a shift in how we think about medical care in space: not as something that requires a doctor to be present, but as something that can be distributed across a crew, with technology acting as the expert guide.
Menon's presence on this mission reflects a broader pattern in space exploration. The ISS has become a genuinely international laboratory, with astronauts and cosmonauts from multiple nations working toward shared scientific goals. Menon joins a growing cohort of astronauts whose backgrounds span continents and whose expertise draws on diverse traditions of scientific training. His launch is routine in the sense that Soyuz flights to the ISS happen regularly, with practiced efficiency. But it is also a marker of something larger: the normalization of space as a place where humans of all origins contribute to knowledge that belongs to everyone. The work he and his crewmates will conduct over the next eight months will inform decisions about how humans will live and work beyond Earth for decades to come.
Citations marquantes
Research will examine how the human body responds to prolonged exposure to microgravity, including blood circulation, vein structure, and blood composition— NASA mission description
Envie de l'histoire complète ?
Lire l'original sur Free Press Journal ↗
Science & Space